(1111 Biehl J, Socal MP, Amon JJ. The judicialization of health and the quest for state accountability: evidence from 1,262 lawsuits for access to medicines in southern Brazil. Health Hum Rights [Internet]. 2016 [cited 2019 Mar 12];18(1):209-20. Available from: https://pdfs.semanticscholar.org/b787/0d87ead2460a5cb8c41059e90bf7236a271e.pdf?_ga=2.169565409.1195865572.1552323956-1942654150.1552323956
https://pdfs.semanticscholar.org/b787/0d...
) Biehl, J.; Socal, M.P.; Amon J.J. The judicialization of health and the quest for state accountability: Evidence from 1,262 lawsuits for access to medicines in Southern Brazil Health and human rights, 18(1), 209. (2016) Brazil |
To evaluate the claims, offering empirical evidence that myth counters prevail and claim the heterogeneity of the phenomenon of judicialization. |
Most applicants are, in fact, poor and older individuals who do not live in major metropolitan areas. They also depend on the State to provide their legal representation and most of the requested medicines were already on government forms. |
(1212 Cabral I, Rezende LF. [Analysis of individual lawsuits on supplying journal in São João da Boa Vista, São Paulo, Brazil]. R Dir Sanit [Internet]. 2015 [cited 2019 Mar 12];16(1):59-77. Available from: https://doi.org/10.11606/issn.2316-9044.v16i1p59-77 Portuguese. https://doi.org/10.11606/issn.2316-9044....
) Cabral, I.; Rezende, L.F. Análise das ações judiciais individuais para fornecimento de medicamentos em São João da Boa Vista Rev de Direito Sanitário. 2015; v. 16, n. 1, p. 59-77. Brazil |
To analyze individual lawsuits taken to guarantee access to medicines in the municipality of São João da Boa Vista -SP. |
Most of lawsuits were filed by women represented by private lawyers asking for medication. |
(1313 Chieffi AL, Barata RB. [“Judicialization” of public health policy for journal of medicines]. Cad Saúde Pública [Internet]. 2009 [cited 2019 Mar 12];25(8):1839-49. Available from: http://dx.doi.org/10.1590/S0102-311X2009000800020 Portuguese. http://dx.doi.org/10.1590/S0102-311X2009...
) Chieffi, A.L.; Barata, R.B. Judicialização da política pública de assistência farmacêutica e equidade Cad de Saúde Pública. 2009; v. 25, p. 1839-1849 Brazil |
To analyze the lawsuit used to obtain medicines through the Department of Health of São Paulo State. |
Most of the litigation was filed by private lawyers, 47% had private network prescriptions and 73% of the cases were from patients with social vulnerability. |
(1414 Chieffi AL, Barata RCB. Legal suits: pharmaceutical industry strategies to introduce journal drugs in the brazilian public healthcare system. Rev Saúde Pública [Internet]. 2010 [cited 2019 Mar 12];44(3). Available from: http://dx.doi.org/10.1590/S0034-89102010000300005
http://dx.doi.org/10.1590/S0034-89102010...
) Chieffi, A.L.; Barata, R.C.B Ações judiciais: estratégia da indústria farmacêutica para introdução de novos medicamentos Rev de Saúde Pública. 2010; v. 44, n. 3, p. 421-429. Brazil |
To analyze the concentration in the distribution of lawsuits according to the medicine (manufacturer), prescribing doctor and soliciting attorney of the lawsuit. |
1,309 lawsuits were for acquisition of 14 medications. Most cases were represented by private lawyers and 11 lawyers accounted for 613 (47%) cases. |
(1515 Coelho TL, Ferré F, Neto OHC, Assis AF, Cherchiglia ML, Andrade EIG. Legal and health variations in drug litigation injunctions granted in Minas Gerais. Rev Saúde Pública [Internet]. 2014 [cited 2019 Mar 12];48(5):808-16. Available from: http://dx.doi.org/10.1590/S0034-8910.2014048005286
http://dx.doi.org/10.1590/S0034-8910.201...
) Coelho et al. Variáveis jurídicas e de saúde no deferimento de liminares por medicamentos em Minas Gerais Rev de Saúde Pública. 2014; v. 48, n. 5, p. 808-816. Brazil |
To investigate factors related to the deferral of injunctions by medications. |
Of the 5,072 lawsuits with injunctions, 4,184 (82.5%) were deferred. The medications paroxetine, somatropin and ferrous sulfate were 100% deferred. Escitalopram, diclofenac sodium and nortriptyline obtained a reduction of less than 54.0%. |
(1616 Leitão LCA, Silva PCDD, Simões AEO, Barbosa IC, Pinto MEB, Simões MODS. Analysis of medicine procurement lawsuits in the state journal Paraíba, Brazil. Saúde Soc [Internet]. 2016 [cited 2019 Mar 12];25(3):801-8. Available from: http://dx.doi.org/10.1590/S0104-12902016153819
http://dx.doi.org/10.1590/S0104-12902016...
) Leitão et al. Análise das demandas judiciais para aquisição de medicamentos no estado da Paraíba Saúde e Sociedade. 2016; v. 25, p. 800-807. Brazil |
To describe medical-scientific and health aspects of court injunctions for the supply of medicines to the Court of Paraíba against public agents. |
Seventy-five claims were identified for different medications. The most frequent were the antineoplastic medications, followed by insulin and angiotensin II antagonists. |
(1717 Lopes LC, Nascimento SMS, Camargo IA, Barberato-Filho S, Del Fiol FDS, Osorio-de-Castro CGS. Biological drugs for the treatment of psoriasis in a public health system. Rev Saúde Pública [Internet]. 2014 [cited 2019 Mar 12];48(4):651-61. Available from: http://dx.doi.org/10.1590/S0034-8910.2014048005109
http://dx.doi.org/10.1590/S0034-8910.201...
) Lopes et al. Medicamentos biológicos para o tratamento de psoríase em sistema público de saúde Rev de Saúde Pública. 2014 v. 48, n. 4, p. 651-661. Brazil |
To analyze the access and profile of use, by judicial means, of biological medicines for the treatment of psoriasis. |
There was access by injunction (59.5%). 66% used the biological medication for 13 months, 26.6% abandoned treatment due to worsening of the condition, 20.5% had adverse effects and 13.8% did not have surgery, due to lack of efficacy. |
(1818 journal MAA, Acurcio FDA, Brandão CMR, Faleiros DR, Guerra Jr AA, Cherchiglia ML et al. Judicialization of access to medicines in minas gerais state, southeastern brazil. Rev de Saúde Pública [Internet]. 2011 [cited 2019 Mar 12];45(3). Available from: http://dx.doi.org/10.1590/S0034-89102011005000015
http://dx.doi.org/10.1590/S0034-89102011...
) Machado et al Judicialização do acesso a medicamentos no Estado de Minas Gerais, Brasil Rev de Saúde Pública. 2011; v. 45, p. 590-598. Brazil |
To analyze the profile of claimants and medications pleaded in lawsuits. |
Most of applicants were women, aged 60 or over, retirees, pensioners and housewives. The most requested medications were immunosuppressants. |
(1919 Medeiros M, Diniz D, Doederlein S, Ida V. [The thesis of judicialization of health journal by the elites: medication for mucopolysaccharidosis]. Ciência & Saúde Coletiva [Internet]. 2013 [cited 2019 Mar 12];18(4):1089-98. Available from: http://dx.doi.org/10.1590/S1413-81232013000400022 Portuguese. http://dx.doi.org/10.1590/S1413-81232013...
) Medeiros, M.; Diniz, D.; Doederlein, S. A tese da judicialização da saúde pelas elites: os medicamentos para mucopolissacaridose Ciência & Saúde Coletiva. 2013 v. 18, n. 4. Brazil |
Evaluating the hypothesis of whether the judicialization of medications for the treatment of mucopolysaccharidoses in Brazil would be a lawsuit of economic elites. |
It is not possible to refute or corroborate the thesis of judicialization by elites. There is no way to say that judicialization is a matter of class. |
(2020 Neto OHC, Acurcio FA, Machado MAA, Ferré F, Barbosa FLV, Cherchiglia ML, et al. Doctors, lawyers and pharmaceutical industry on health journal in Minas Gerais, Southeastern Brazil. Rev Saúde Pública [Internet]. 2012 [cited 2019 Mar 12];46(5):784-90. Available from: http://dx.doi.org/10.1590/S0034-89102012000500004
http://dx.doi.org/10.1590/S0034-89102012...
) Neto et al. Médicos, advogados e indústria farmacêutica na judicialização da saúde em Minas Gerais, Brasil Rev de Saúde Pública. 2012; v. 46, p. 784-790. Brazil |
To describe the relationships between prescriber, lawyer, and pharmaceutical industry in lawsuits against the State. |
Among lawsuits of a single office, 43.6% had prescriptions from one doctor X for a medication from a specific laboratory and that same doctor was also the main prescriber of another medication, in which they were represented by two other offices. |
(2121 Pepe VLE, Ventura M, Sant’ana JMB, Figueiredo TA, Souza VDRD, Simas L, Osorio-de-Castro CGS. &journal;#91;Characterization of lawsuits for the supply of “essential” medicines in the state of rio de janeiro, brazil]. Cad Saúde Pública [Internet]. 2010 [cited 2019 Mar 12];26(3):461-71. Available from: http://dx.doi.org/10.1590/S0102-311X2010000300004 Portuguese. http://dx.doi.org/10.1590/S0102-311X2010...
) Pepe et al. Characterization of lawsuits for the supply of "essential" medicines in the State of Rio de Janeiro, Brazil Cad de Saúde Pública. 2010; v. 26, n. 3, p. 461-471. Brazil |
To analyze individual lawsuits for medication supply, considered essential by the Court of Rio de Janeiro State in the judicial decisions of the Second Instance in 2006. |
Of the 321 medications identified in lawsuits, 316 were present in the RENAME. |
(2222 Pereira JG, Pepe VLE. &journal;#91;Judicial access to medicine in paraná: applying a methodological model for lawsuit analysis and monitoring]. R Dir Sanit [Internet]. 2014 [cited 2019 Mar 12];15(2):30-45. Available from: https://doi.org/10.11606/issn.2316-9044.v15i2p30-45 Portuguese. https://doi.org/10.11606/issn.2316-9044....
) Pereira, J.G.; Pepe, V.L.E. Acesso a medicamentos por via judicial no Paraná: aplicação de um modelo metodológico para análise e monitoramento das demandas judiciais Rev de Direito Sanitário. 2015; v. 15, n. 2, p. 30-45. Brazil |
To apply the methodological model developed in the analysis of the individual judicial demands for access to medicines in Paraná State. |
Results showed that the sources used in the study were not enough to identify and quantify all variables proposed in their dimensions, especially some of the indicators of sociodemographic characteristics. |
(2323 Portilla-Pinzón A, López JJ, Montoya-Cañon M, Machado-Alba JE. [Evaluation of prescriptions authorized between 2010 journal 2011 through judicial protection in Bogotá]. Rev Fac Med [Internet]. 2016 [cited 2019 Mar 12];64(4):679-85. Available from: http://dx.doi.org/10.15446/revfacmed.v64n4.53574 Spanish. http://dx.doi.org/10.15446/revfacmed.v64...
) Portilla-Pinzón et al. Evaluation of prescriptions authorized between 2010 and 2011 through judicial protection in Bogotá Rev de la Facultad de Medicina. 2016; v. 64, n. 4, p. 679-685. Colombia |
To evaluate the therapeutic rationality of prescriptions of medicines authorized by guardianship in patients affiliated to the General System of Social Security in Health. |
In 75.5% of the cases, the medication was correlated with the diagnosis and 66% of the patients were exposed to risks of medication interactions. |
(2424 Provin MP, Leite SN, Amaral RG. Social inequalities in lawsuits for drugs. Braz J Pharm Sci [Internet]. 2013 [cited 2019 Mar 12];49(3):465-74. Available from: http://dx.doi.org/10.1590/S1984-82502013000300008
http://dx.doi.org/10.1590/S1984-82502013...
) Provin, M.P.; Leite, S.N.; Amaral, R.G. Social inequalities in lawsuits for drugs Brazilian Journal of Pharmaceutical Sciences2013; v. 49, n. 3, p. 465-474. Brazil |
To characterize lawsuits that requested medicines considering the economic profile of their impetrants. |
Residents of wealthier regions were responsible for more frequent lawsuits. Lawsuit costs were four times higher in the richer regions compared to the poorer region. |
(2525 Ramos KA, Ferreira ASD. [Analysis of the demand for medicines journal off label use through lawsuits in the state health secretariat of minas gerais]. R Dir Sanit [Internet]. 2013 [cited 2019 Mar 12];14(1):98-121. Available from: https://doi.org/10.11606/issn.2316-9044.v14i1p98-121 Portuguese. https://doi.org/10.11606/issn.2316-9044....
) Ramos, K.A.; Ferreira, A.S.D. Análise da demanda de medicamentos para uso off label por meio de ações judiciais na Secretaria de Estado de Saúde de Minas Gerais Rev de Direito Sanitário. 2013; v. 14, n. 1, p. 98-121. Brazil |
To investigate the occurrence of a medication court application for indications not approved by the Agência Nacional de Vigilância Sanitária (Brazilian National Sanitary Surveillance Agency) through lawsuits against Minas Gerais State in 2010. |
212 applications for off-label medications were identified, of which 46% were not included in pharmaceutical assistance programs. |
(2626 Sant‘ana JMB, Pepe VLE, Figueiredo TA, Osorio-de-Castro CGS, Ventura M. Rational therapeutics: health-related elements in lawsuits journal medicines. Rev Saúde Pública [Internet]. 2011 [cited 2019 Mar 12];45(4). Available from: http://dx.doi.org/10.1590/S0034-89102011005000042
http://dx.doi.org/10.1590/S0034-89102011...
) Sant'Ana et al. Rational therapeutics: health-related elements in lawsuits demanding medicines Rev de Saúde Pública. 2011; v. 45, n. 4, p. 714-721. Brazil |
To characterize the main procedural, medical-scientific and health elements that support the decisions of the individual judicial demands for medicines considered essential. |
All lawsuits contained prescriptions and medical certificates. The prescriptions were in discrepancy with the legislation. There were no medical examinations in any of the lawsuits and 7.4% consisted of complementary tests. |
(2727 Silva EM, de Almeida, KC, Pessoa GSC. [Analysis of drug expenditure with judicialization journal the federal district, brazil]. Cad Ibero-Amer Dir Sanit [Internet]. 2017 [cited 2019 Mar 12];6(1):112-26. Available from: http://dx.doi.org/10.17566/ciads.v6i1.358 Portuguese. http://dx.doi.org/10.17566/ciads.v6i1.35...
) Silva, E.; de Almeida, K.C.; Pessoa, G.S.C Análise do gasto com judicialização de medicamentos no Distrito Federal, Brasil Cadernos Ibero-Americanos de Direito Sanitário, 2017; 6(1), 112-126. Brazil |
To analyze the profile of public health spending in the Federal District with non-standard medications occurs at this location. |
Total expenses were 43.7 million reais. Among the medications with the highest expenditure, the recombinant factor IX (haemophilia treatment) was observed as the most responsible (22.53%). |
(2828 Souza ÍP, Bellato R, Araújo LFS, Almeida KBB, Nepomuceno MAS, Mufato LF. [Right to health in the court journal justice: demand for oncology drugs]. Rev RENE [Internet]. 2012 [cited 2019 Mar 12];13(4):919-28. Available from: https://www.redalyc.org/pdf/3240/324027983022.pdf Portuguese. https://www.redalyc.org/pdf/3240/3240279...
) Souza et al. Direito à saúde no tribunal de justiça: demanda por medicações em oncologia Rev da Rede de Enfermagem do Nordeste. 2012; v. 13, n. 4. Brazil |
To describe the demand for the right to health in the Court of Mato Grosso State on medicines for people with cancer. |
There were 25 lawsuits for cancer medications, 32% cited the amount of medicine needed, 60% determined the medication delivery period, 16% brought the dosage and 4% contained the deadline to meet the demand determined by the judge. |
(2929 Stamford A, Cavalcanti M. Legal decisions on access to medicines in journal northeastern brazil. Rev Saúde Pública [Internet]. 2012 [cited 2019 Mar 12];46(5). Available from: http://dx.doi.org/10.1590/S0034-89102012000500005
http://dx.doi.org/10.1590/S0034-89102012...
) Stamford, A.; Cavalcanti, M. Decisões judiciais sobre acesso aos medicamentos em Pernambuco Rev de Saúde Pública. 2012; v. 46, p. 791-799. Brazil |
To analyze the decisions of the legal system on access of the population to medicines in the Sistema Único de Saúde (Brazilian Unified Health) System by judicial means regarding decision criteria and possible political and economic pressures. |
The Federal Constitution and medical prescription were identified as a decision criterion in lawsuits. |
(3030 Vieira FS, Zucchi P. Distortions to national drug policy caused by lawsuits journal brazil. Rev Saúde Pública [Internet]. 2007 [cited 2019 Mar 12];41(2). Available from: http://dx.doi.org/10.1590/S0034-89102007000200007
http://dx.doi.org/10.1590/S0034-89102007...
) Vieira, F.S.; Zucchi, P. Distorções causadas pelas ações judiciais à política de medicamentos no Brasil Rev de Saúde Pública. 2007; v. 41, p. 214-222. Brazil |
To describe the effects of lawsuits that requires the supply of medications, in relation to aspects of the national medication policy. |
The total expense was of 876 thousand reais (Brazilian currency) for items that are not part of the Municipal Relation of Essential Medicines. Of the total expenditure, 75% were allocated to the acquisition of antineoplastic agents and two of these medications were not registered in Brazil. |
(3131 Wang DWL, Vasconcelos NP, Oliveira VE, Terrazas FV. [The impacts of health care judicialization journal the city of Sao Paulo: public expenditure and federal organization]. Rev Adm Pública [Internet]. 2014 [cited 2019 Mar 12];48(5):1191-1206. Available from: http://dx.doi.org/10.1590/0034-76121666 Portuguese. http://dx.doi.org/10.1590/0034-76121666...
) Wang et al. Os impactos da judicialização da saúde no município de São Paulo: gasto público e organização federativa Rev de Administração Pública-RAP. 2014; v. 48, n. 5. Brazil |
To analyze the impact of health judicialization in the city of São Paulo. |
Approximately 55% of health care expenditures are spent on the supply of State or Union medicines and 45% on non-contemplated SUS (Unified Health System) treatments. |